Stanford Cancer Institute: 25 Years of LKB1/STK11 Tumor Suppressor
Stanford Cancer Institute presents a seminar on 25 years of LKB1/STK11 tumor suppressor research, featuring Reuben Shaw on breakthroughs in cancer research and translational oncology.
